Ionizing radiation improves survival in mice bearing intracranial high- grade gliomas injected with genetically modified herpes simplex virus

Clinical Cancer Research

Volumn 5, Issue 6, 1999, Pages 1517-1522

  Bradley, Jeffrey D ^a,c   Kataoka, Yasushi ^a   Advani, Sunil ^a   Chung, Su Mi ^a   Arani, Ramin B ^b   Gillespie, G Yancey ^b   Whitley, Richard J ^b   Markert, James M ^b   Roizman, Bernard ^a   Weichselbaum, Ralph R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; GENE THERAPY; GLIOMA; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IONIZING RADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BRAIN NEOPLASMS; CANCER VACCINES; COMBINED MODALITY THERAPY; FEMALE; GLIOMA; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RANDOM ALLOCATION; SOFT TISSUE NEOPLASMS; SURVIVAL RATE; TUMOR CELLS, CULTURED; X-RAYS;

EID: 0033018852     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Andersen, A. P. Postoperative irradiation of glioblastomas. Results in a randomized series. Acta Radiol. Oncol. Radiat. Phys. Biol., 17: 475-484, 1978.
2. Halperin, E. C., Herndon, J., Schold, S. C., Brown, M., Vick, N., Cairncross, J. G., Macdonald, D. R., Gaspar, L., Fischer, B., Dropcho, E., Rosenfeld, S., Morowitz, R., Piepmeier, J., Hait, W., Byrne, T., Salter, M., Imperato, J., Khandekar, J., Paleologos, N., Burger, P., Bentel, G. C., and Friedman, A. A Phase III randomized prospective trial of external beam radiotherapy, mitomycin, C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer Consortium. Int. J. Radiat. Oncol. Biol. Phys., 34: 793-802, 1996.
3. Wallner, K. E., Galicich, J. H., Krol, G., Arbit, E., and Malkin, M. G. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int. J. Radiat. Oncol. Biol. Phys., 16: 1405-1409, 1989.
4. Culver, K. W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E. H., and Blaese, R. M. In vivo gene transfer with relroviral vector-producer cells for treatment of experimental brain tumors. Science (Washington DC), 256: 1550-1552, 1992.
5. Boviatsis, E. J., Park, J. S., Sena-Esteves, M., Kramm, C. M., Chase, M., Efird, J. T., Wei, M. X., Breakefield, X. O., and Chiocca, E. A. Long-term survival of rats harboring brain neoplasms treated with gancyclovir and herpes simplex virus vector that remains an intact thymidine kinase gene. Cancer Res., 54: 5745-5751, 1994.
6. Namba, H., Tagawa, M., Iwadate, Y., Kimura, M., Sueyoshi, K., and Sukiyama, S. Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells. Hum. Gene Ther., 9: 5-11, 1998.
7. Chou, J., Kern, E. R., Whitley, R. J., and Roizman, B. Mapping of herpes simplex virus-1 neurovirulence to γ 1 34.5, a gene nonessential for growth culture. Science (Washington DC), 250: 1262-1266, 1990.
8. Martuza, R. L., Malick, A., Markert, J. M., Ruffner, K. L., and Coen, D. M. Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science (Washington DC), 252: 854-856, 1991.
9. Mineta, T., Markert, J. M., Takamiya, Y., Coen, D. M., Rabkin, S. D., and Martuza, R. L. CNS tumor therapy by attenuated herpes simplex viruses. Gene Ther., 1: S78, 1994.
10. Mineta, T., Rabkin, S. D., and Martuza, R. L. Treatment of malignant gliomas using gancyclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant. Cancer Res., 54: 3963-3966, 1994.
11. Mineta, T., Rabkin, S. D., Yazaki, T., Hunter, W. D., and Martuza, R. L. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat. Med., 1: 938-943, 1995.
12. Chambers, R., Gillespie, G. Y., Soroceanu, L., Andreansky, S., Chatterjee, S., Chou, J., Roizman, B., and Whitley, R. J. Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma. Proc. Natl. Acad. Sci. USA, 92: 1411-1415, 1995.
13. Markert, J. M., Malick, A., Coen, D. M., and Martuza, R. L. Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir. Neurosurgery, 32: 597-603, 1993.
14. Whitley, R. J., Kern, E. R., Chatterjee, S., Chou, J., and Roizman, B. Replication, establishment of latency, and induced reactivation of herpes simplex virus γ 1 34.5 deletion mutants in rodent models. J. Clin. Invest., 91: 2837-2843, 1993.
15. Markovitz, N. S., Baunoch, D., and Roizman, B. The range and distribution of murine central nervous system cells infected with the gamma(1)34.5-mutant of herpes simplex virus 1. J. Virol., 71: 5560-5569, 1997.
16. Advani, S., Sibley, G. S., Song, P. Y., Hallahan, D. E., Kataoka, Y., Roizman, B., and Weichselbaum, R. R. Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors. Gene Ther., 5: 160-165, 1998.
17. Machado, S. G., and Bailey, K. R. Assessment of interaction between carcinogens in long-term factorially designed animal experiments. Biometrics, 41: 539-545, 1985.